Immunopharmacology and Immunotoxicology · 2018 · 30 citations · 33 references
MedicineOncologyPharmacologyCancer PharmacologyDrug DiscoveryMolecular OncologyAngiogenesisAntibody CharacterizationCancer NanomedicineNanomedicineTargeted Cancer TherapyTherapeutic Monoclonal AntibodiesAntibody Targeting LigandsCancer NanotherapyMonoclonal Antibody TherapeuticsNanobodiesNanobody DiscoveryNanoparticle Drug TargetingTumor Targeting LigandsWestern Blotting
OBJECTIVES: Angiogenesis targeting is an attractive approach for cancer treatment. Delta-like ligand 4 (DLL4) plays a pivotal role in neovascular development and its inhibitors have recently entered clinical trials for solid tumors. The aim of this study was to evaluate the possibilities of using anti-DLL4 antibody fragment as an angiogenesis maturation inhibitor. MATERIALS AND METHODS: In this study, a DLL4-specific Nanobody, named 3Nb3, was selected and assessed by western blotting and internalization assays. Functional assessments included MTT, apoptosis, and chicken chorioallantoic membrane (CAM) assays. RESULTS: Based on the results, 3Nb3 specifically binds to DLL4 and internalizes into MKN cell. Furthermore, 3Nb3 significantly inhibited the proliferation of cells and also neovascularization in the CAM. CONCLUSIONS: These data demonstrated the potential of Nanobody for application in targeting DLL4. Our findings may provide a basis for the development of novel therapeutic techniques to inhibit growth and neovascularization of tumors.
33
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Irene Noguera‐Troise, Christopher Daly, Nicholas Papadopoulos et al. · Nature · 2006 · 1K citations
Medicine, Cancer Biology, Oncology +14
Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis
John Brady Ridgway, Gu Zhang, Yan Wu et al. · Nature · 2006 · 982 citations
Medicine, Cancer Biology, Oncology +12
Camelid immunoglobulins and nanobody technology
Serge Muyldermans, Toya Nath Baral, V. Cortez Retamozzo et al. · Veterinary Immunology and Immunopathology · 2008 · 539 citations · Full text